Louisiana health plans must cover medically necessary care for SCN2A-related conditions, with genetic testing coverage applying to plans issued or renewed starting January 1, 2027.
Louisiana health plans must cover medically necessary genetic testing for SCN2A-related conditions when a treating provider orders it. Plans may require prior approval under the same rules they use for other benefits.
Health plans must cover medically necessary care for SCN2A-related conditions, including medicines, therapy, equipment, and feeding support. Plans may charge cost sharing no higher than for other medical or surgical care.
Plans cannot deny covered testing or medically necessary care because of disability, developmental status, or a preexisting condition. They must explain medical-need denials in writing, and enrollees may appeal.
Health plans must cover genetic testing to diagnose SCN2A-related conditions when a treating doctor or advanced practice provider orders it and it is medically necessary. This applies to health coverage plans delivered, issued, renewed, or otherwise contracted for in Louisiana. The law says the plan must find the test medically necessary and that the treating provider determines medical necessity. Plans may require prior approval if they apply that rule without discrimination and no more strictly than for other benefits. The testing coverage rule applies to plans delivered, issued, renewed, or otherwise contracted for in Louisiana on or after January 1, 2027.
Health plans must cover medically necessary treatment for SCN2A-related conditions. The requirement applies to medically necessary treatment for SCN2A-related conditions under health coverage plans, except limited benefit policies and contracts. Covered care includes medicines, therapy, equipment, and feeding or nutrition services, as well as other care the treating provider finds medically necessary. Plans may charge copayments, deductibles, or coinsurance no higher than for other medical or surgical benefits. Limited benefit health insurance policies and contracts are excluded. The law takes effect upon the governor's signature.
Plans must not deny covered testing or medically necessary treatment because of disability, developmental status, or a preexisting condition. They must explain medical-need denials in writing. These protections apply to genetic testing and medically necessary treatment covered under the law for SCN2A-related conditions. A written denial must give the reasons and explain why the request does not meet medical-need standards. An enrollee may appeal a denial under the appeal process referenced in the law. The law takes effect upon the governor's signature.
No hearings or votes scheduled.